Atara Biotherapeutics, Inc. short interest in 2019
In 2019, Atara Biotherapeutics, Inc.'s disclosed short interest ran from 14.04% of shares outstanding on 15 Jan 2019 to 18.03% on 31 Dec 2019, a change of +3.99 percentage points. The year's high was 20.28% on 15 Jul 2019 and its low 14.04% on 15 Jan 2019, averaging 17.05% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 26.20 days on 15 Feb 2019. Full history: Atara Biotherapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2019 in figures
- Start of year
- 14.04% (15 Jan 2019)
- End of year
- 18.03% (31 Dec 2019)
- Change
- +3.99 pp
- High
- 20.28% (15 Jul 2019)
- Low
- 14.04% (15 Jan 2019)
- Average
- 17.05%
- Highest days to cover
- 26.20 (15 Feb 2019)
- SEC filings marked
- 9
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2019 | 14.04% | 7.83 | |
| 31 Jan 2019 | 14.09% | 14.55 | |
| 15 Feb 2019 | 15.93% | 26.20 | |
| 28 Feb 2019 | 16.85% | 15.06 | 10-K filed, results (8-K) |
| 15 Mar 2019 | 17.24% | 18.02 | |
| 29 Mar 2019 | 15.67% | 19.24 | |
| 15 Apr 2019 | 15.18% | 16.29 | |
| 30 Apr 2019 | 14.97% | 13.61 | |
| 15 May 2019 | 16.90% | 6.84 | 10-Q filed, results (8-K) |
| 31 May 2019 | 17.23% | 13.11 | |
| 14 Jun 2019 | 17.98% | 13.11 | |
| 28 Jun 2019 | 17.15% | 8.41 | |
| 15 Jul 2019 | 20.28% | 12.77 | |
| 31 Jul 2019 | 15.10% | 7.81 | results (8-K) |
| 15 Aug 2019 | 15.94% | 9.16 | 10-Q filed, results (8-K) |
| 30 Aug 2019 | 16.57% | 16.68 | |
| 13 Sep 2019 | 15.81% | 10.69 | |
| 30 Sep 2019 | 18.76% | 10.43 | |
| 15 Oct 2019 | 20.07% | 15.65 | |
| 31 Oct 2019 | 20.11% | 17.99 | |
| 15 Nov 2019 | 18.33% | 17.11 | 10-Q filed, results (8-K) |
| 29 Nov 2019 | 19.27% | 17.45 | |
| 13 Dec 2019 | 17.67% | 15.40 | |
| 31 Dec 2019 | 18.03% | 13.92 |
See also: Atara Biotherapeutics, Inc.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.